Stem Cells: Worldwide Markets for Transplantation and Cord Blood Banking (Projections for Stem Cell Use in Cancer, Alzheimer’s, Diabetes, Arthritis and Other Diseases) (Related Reports)

Stem Cells: Worldwide Markets for Transplantation and Cord Blood Banking (Projections for Stem Cell Use in Cancer, Alzheimer’s, Diabetes, Arthritis and Other Diseases)


January 1, 2012
160 Pages - SKU: KLI6490034
License type:
Online Download      US $1,995.00
Global Site License      US $3,990.00
Departmental Site License (one location, 10 users)      US $2,995.00
Menopausal Hot Flashes - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Menopausal Hot Flashes - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Menopausal Hot Flashes - Pipeline Review, H1 2014’, provides an overview of the Menopausal Hot Flashes’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
Lewy body Dementia - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Lewy body Dementia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Lewy body Dementia - Pipeline Review, H1 2014’, provides an overview of the Lewy body Dementia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
Visceral Pain - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Visceral Pain - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Visceral Pain - Pipeline Review, H1 2014’, provides an overview of the Visceral Pain’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Visceral  |  read more...
$2,000.00
Polycythemia Vera - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Polycythemia Vera - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Polycythemia Vera - Pipeline Review, H1 2014’, provides an overview of the Polycythemia Vera’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Polycythemia  |  read more...
$2,000.00
Bacterial Pneumonia - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Bacterial Pneumonia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Bacterial Pneumonia - Pipeline Review, H1 2014’, provides an overview of the Bacterial Pneumonia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Bacterial  |  read more...
$2,000.00
Retinal Vein Occlusion - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Retinal Vein Occlusion - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Retinal Vein Occlusion - Pipeline Review, H1 2014’, provides an overview of the Retinal Vein Occlusion’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
Bone Marrow Transplantation - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Bone Marrow Transplantation - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Bone Marrow Transplantation - Pipeline Review, H1 2014’, provides an overview of the Bone Marrow Transplantation’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
Food Allergy - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Food Allergy - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Food Allergy - Pipeline Review, H1 2014’, provides an overview of the Food Allergy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Food  |  read more...
$2,000.00
Hepatitis C: Game changing regimens to revolutionise treatment landscape - KOL Insight
4/1/2014 | published by: FirstWord
Introduction Approval of Gilead’s once daily oral nucleotide inhibitor Sovaldi marks a significant step in the treatment of hepatitis C (HCV). With efficacy over 90% in GT1/2/3/4 patients, this safe, best in  |  read more...
$4,995.00
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018
4/4/2014 | published by: MarketsandMarkets
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018 Over the  |  read more...
$4,650.00